Target intelligence / Profile preview

Ribosomal protein L23a pseudogene 75 (RPL23AP75)

Target
RPL23AP75
Molecular classification
Other (Pseudogene), Ribosomal protein L23a pseudogenes
01

Overview

Ribosomal protein L23a pseudogene 75 (RPL23AP75) is a processed pseudogene in the human genome related to the ribosomal protein L23a gene (RPL23A), which encodes a component of the large 60S ribosomal subunit. There are over 90 RPL23A pseudogenes dispersed throughout the human genome, including RPL23AP75, none of which are known to produce a functional protein product[3][4]. Pseudogenes such as RPL23AP75 lack protein-coding capability, typically due to accumulated mutations or lack of necessary regulatory sequences. These pseudogenes are sometimes annotated and tracked in genomic databases for completeness or evolutionary studies but are not generally relevant as drug targets, biological receptors, or enzymes. There is currently no evidence linking RPL23AP75 to disease mechanisms, biomarker utility, or therapeutic relevance[4][3]. For research involving ribosomal protein L23a, focus should be on the intact RPL23A gene, not pseudogene family members such as RPL23AP75[3].

Other names
RPL23A_32_1546RPL23AP75

Beyond the preview

Go deeper on Ribosomal protein L23a pseudogene 75 (RPL23AP75).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L23a pseudogene 75 (RPL23AP75).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call